Robert Michael - AbbVie Vice President Controller
4AB Stock | EUR 153.42 0.48 0.31% |
President
Mr. Robert A. Michael serves as Chief Financial Officer, Senior Vice President of the Company. Mr. Michael was AbbVies Vice President, Controller, since March 1, 2017 and served as AbbVies Vice President, Treasurer from 2015 to 2016, and as Vice President, Controller, Commercial Operations from 2013 to 2015. He joined Abbott Laboratories in 1993 and held numerous positions in the finance organization. since 2018.
Age | 53 |
Tenure | 6 years |
Phone | 847 932 7900 |
Web | https://www.abbvie.com |
AbbVie Management Efficiency
The company has return on total asset (ROA) of 0.0991 % which means that it generated a profit of $0.0991 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.7239 %, meaning that it generated $0.7239 on every $100 dollars invested by stockholders. AbbVie's management efficiency ratios could be used to measure how well AbbVie manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 9 records | PRESIDENT Age | ||
Shawn Vammen | Superior Plus Corp | N/A | |
Beth Summers | Superior Plus Corp | N/A | |
Ed Bechberger | Superior Plus Corp | N/A | |
Rob Dorran | Superior Plus Corp | N/A | |
Michael Farrell | Superior Plus Corp | N/A | |
Gregory McCamus | Superior Plus Corp | N/A | |
Jay Bachman | Superior Plus Corp | N/A | |
Andrew Peyton | Superior Plus Corp | 55 | |
Keith Wrisley | Superior Plus Corp | N/A |
Management Performance
Return On Equity | 0.72 | |||
Return On Asset | 0.0991 |
AbbVie Inc Leadership Team
Elected by the shareholders, the AbbVie's board of directors comprises two types of representatives: AbbVie inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AbbVie. The board's role is to monitor AbbVie's management team and ensure that shareholders' interests are well served. AbbVie's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AbbVie's outside directors are responsible for providing unbiased perspectives on the board's policies.
Carlos Alban, Executive Vice President - Commercial Operations | ||
Robert Michael, Vice President Controller | ||
Jeffrey Stewart, Senior Vice President U.S. Commercial Operations | ||
Brett Hart, Independent Director | ||
William Chase, Executive Vice President CFO | ||
Roxanne Austin, Independent Director | ||
Perry Siatis, Gen VP | ||
Azita SalekiGerhardt, Senior Vice President - Operations | ||
Scott Reents, VP CFO | ||
Edward Rapp, Independent Director | ||
Richard Gonzalez, Chairman of the Board, CEO | ||
Brian Durkin, Vice President Controller | ||
Thomas Hurwich, Vice President Controller | ||
Frederick Waddell, Independent Director | ||
Robert Alpern, Independent Director | ||
Thomas Hudson, VP Officer | ||
Glenn Tilton, Lead Independent Director | ||
Henry Gosebruch, Executive Vice President Chief Strategy Officer | ||
Elizabeth Shea, VP Relations | ||
Rebecca Roberts, Independent Director | ||
Edward Liddy, Independent Director | ||
William Burnside, Independent Director | ||
Timothy Richmond, Senior Vice President - Human Resources | ||
Nicholas Donoghoe, Senior Vice President - Enterprise Innovation | ||
Laura Schumacher, Executive Vice President - Business Development, External Affairs, General Counsel | ||
Roy Roberts, Independent Director | ||
Michael Severino, Executive Vice President - Research & Development, Chief Scientific Officer | ||
Melody Meyer, Director |
AbbVie Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AbbVie a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.72 | |||
Return On Asset | 0.0991 | |||
Profit Margin | 0.20 % | |||
Operating Margin | 0.39 % | |||
Current Valuation | 331.38 B | |||
Shares Outstanding | 1.77 B | |||
Shares Owned By Insiders | 0.12 % | |||
Shares Owned By Institutions | 71.51 % | |||
Price To Earning | 22.27 X | |||
Price To Book | 18.07 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for AbbVie Stock analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |